Overexpression of HOTAIRM1 was independently associated with worse outcome in the entire series of 215 IR-AML patients, with shorter OS (P = 0.001) and LFS (P < 0.001) and higher CIR (P = 0.04). The gene discussed is HOTAIRM1; the disease is acute myeloid leukemia.